We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£515.00
It has never been this cheap. We have no record of a lower price.
£515 today · cheaper than every other day in the last 3 months
Alpha-1 Antitrypsin Deficiency Treatment Outlook in India
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 23 days · 23 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 23 days • 1 price levels
Price Analysis
Most common price: £515 (23 days, 100.0%)
Price range: £515 - £515
Price levels: 1 different prices over 23 days
Description
Key Features
Covers the 2023-2028 outlook for Alpha-1 antitrypsin deficiency treatments specifically within the Indian market.
Provides latent demand estimates in millions of U.S. dollars across more than 4,900 cities in India.
Includes potential industry earnings (P.I.E.) data to help identify market opportunities.
Offers comparative benchmarks by reporting the percent share of each city relative to its state, union territory, and India as a whole.
Supports the development of strategic distribution and sales force planning through detailed statistical data.
Product Specifications
- Format
- paperback
- ASIN
- B0BGKQZ3R6
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 14 September 2022
- Listed Since
- 29 September 2022
Similar Products You Might Like
Alpha-1 Antitrypsin Deficiency Treatment Outlook in India
Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028
Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028
World Outlook: Alpha-1 Antitrypsin Deficiency Treatments
The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in China
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan
Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies for US Zip Codes
Alpha-1 Antitrypsin Drug Outlook 2023-2028 US Zip Codes
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study
World Outlook for Idiopathic Pulmonary Fibrosis Treatments
US Air Treatment Products Outlook 2023-2028 Study
Anti-Inflammatory Asthma Drugs Outlook 2023-2028 Report
US Animal Health API Outlook 2023-2028 Report
Advanced Therapy Medicinal Products Outlook India 2023-2028
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
Asthma Treatments in India Outlook 2023-2028 Study
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
2023-2028 US Advanced Therapy Medicinal Products Outlook
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States